LR

Lingeswara Rao Nagireddi

Director Director DIN 07150700
DIN 07150700 First appointment Jun 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Lingeswara Rao Nagireddi

Data last updated:

Lingeswara Rao Nagireddi was a Director at Macto Pharmaceuticals Private Limited (2015–2016) and Director at Hafwen Pharmaceuticals Private Limited (from 2016). The companies operate in Pharma.

DIN 07150700
Primary Designation Director
Industry Pharma
First Appointment 15 Jun 2015
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jun 20152015₹54.3 Lakh (FY 2025)Active
Director10 Mar 20162016₹6.6 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hafwen Pharmaceuticals Private Limited
Macto Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Lingeswara Rao Nagireddi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lingeswara Rao Nagireddi

Lingeswara Rao Nagireddi was first appointed on 15 Jun 2015 as Director at Macto Pharmaceuticals Private Limited. The most recent appointment on record is 10 Mar 2016 at Hafwen Pharmaceuticals Private Limited.

Lingeswara Rao Nagireddi held 2 earlier board appointments: Macto Pharmaceuticals Private Limited (Director, 15 Jun 2015 to 01 Feb 2016); Hafwen Pharmaceuticals Private Limited (Director, from 10 Mar 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available